UBS Group’s NEVRO CORP. NVRO Stock Holding History

UBS Group’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,500	Closed	-$110K	–	11072
2022 Q2	$110K	Hold	2,500	–	–	﹤0.01%	5359
2022 Q1	$181K	Buy	+2,500	New	+$180K	﹤0.01%	5444

Other funds holding NVRO

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group's NVRO Position: Q2 2025 in Review

UBS Group sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 123,082 shares — an estimated $719K sold.

UBS Group first reported a position in NVRO in Q4 2014 and held it in 42 quarters. The position peaked at $17.4M in Q3 2023. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

UBS Group reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
UBS Group sold 123,082 NEVRO CORP. shares in Q2 2025, an estimated $719K.
UBS Group first reported a position in NEVRO CORP. in Q4 2014 and held it in 42 quarters.
UBS Group's NEVRO CORP. position peaked at $17.4M in Q3 2023.
1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on UBS Group's 13F filing for Q2 2025, filed 14 Aug 2025.